Law firm says Trump order targeting it specifically is attack on rule of law
The law firm Perkins Coie is suing the Trump administration, alleging that a recent executive order targeting the firm is unconstitutional and aims to punish it for representing clients and causes that are opposed to the administration.
President Trump signed an executive order last week, “Addressing Risks from Perkins Coie LLP,” that accused the firm of “dishonest and dangerous activity” that sought to overturn laws and elections, and also said it “racially discriminates against its own attorneys and staff” through its diversity, equity and inclusion programs.
In the lawsuit filed Tuesday in federal court in Washington, D.C., attorneys for Perkins Coie call the executive order “an affront to the Constitution and our adversarial system of justice.”
“Its plain purpose is to bully those who advocate points of view that the President perceives as adverse to the views of his Administration, whether those views are presented on behalf of paying or pro bono clients,” the lawsuit says.
Trump’s executive order, it adds, presents a threat to Perkins’ Coie’s ability to represent the interests of its clients and its ability to operate as a business. The suit is asking the court to strike down the order and to prevent it from being implemented.
The Justice Department did not immediately respond to a request for comment.
Trump’s executive order accused Perkins’ Coie of a range of nefarious actions over the years allegedly seeking to undermine democratic elections as well as the integrity of U.S. courts and law enforcement.
The order specifically mentions the firm’s representation of Hillary Clinton’s 2016 campaign, and the role attorneys at Perkins Coie played in the creation of a dossier of unsubstantiated allegations about possible Trump-Russia ties.
The lawsuit pushes back against any allegation of wrongdoing. It notes that Trump filed a lawsuit in 2022 against Perkins Coie, Hillary Clinton and others alleging a conspiracy against Trump. The case was dismissed months later by a federal court.
It also notes that the two attorneys who led the firm’s work for the Clinton campaign no longer work for Perkins Coie. One of lawyers, Michael Sussmann, was charged by a Justice Department special counsel in connection with his work related to the dossier. A jury found him not guilty at trial.
Trump’s order also accuses the law firm of racial discrimination because of it diversity, equity and inclusion policies.
The lawsuit pushes back on that accusation as well. Perkins Coie, it says, is committed to diversity and inclusion, but “does not discriminate against its attorneys or employees on the basis of race or otherwise.”
The firm’s attorneys say Trump’s order is unconstitutional on several grounds, including violations of the First, Fifth and Sixth Amendments.
Erick is an ‘extremely dangerous’ Category 4 hurricane near Mexico’s Pacific coast
The major storm threatens to unleash destructive winds near where the eye crashes ashore, flash floods and a dangerous storm surge, forecasters said.
U.S. resumes visas for foreign students but demands access to social media accounts
The U.S. State Department said it is restarting the process for foreigners applying for student visas but all applicants will now be required to unlock their social media accounts for review.
Israeli president calls on the world to help destroy Iran nuclear sites
Israeli President Isaac Herzog spoke with NPR in his official residence in Jerusalem on Wednesday, as President Trump was still weighing whether to intervene.
Screen addiction and suicidal behaviors are linked for teens, a study shows
The study, published in JAMA, followed teens for years and evaluated addictive behaviors, as well as suicidality.
Trump administration cuts specialized suicide prevention service for LGBTQ+ youth
The 988 Suicide and Crisis Prevention Lifeline included a service that provided specialized suicide prevention support by phone and text for LGBTQ+ kids. That's ending.
HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
